From: The Eurolight project: the impact of primary headache disorders in Europe. Description of methods
Survey | Denominator (n) | Responders (n) | Responder-rate (%) | Gender (% female) | Age (year) mean (SD) |
---|---|---|---|---|---|
Austria | Unknown, but not >6,000 | 646 | Incalculable | 70 | 48.8 (16.0) |
France | 2,400 | 876 | 36.5 | 68 | 50.2 (16.7) |
Germany | 3,000 | 338 | 11.3 | 57 | 44.6 (12.5) |
Ireland | Members 1,500 | 195 | 13.0 | 66 | 49.4 (14.0) |
Relatives unknown | 73 | Incalculable | |||
Italy | 3,500 | 500 | 14.3 | 58 | 43.4 (12.6) |
Lithuania | 1,137 | 616 | 54.2 | 59 | 40.9 (13.8) |
Luxembourg | 6,498 | 2,023 | 31.1 | 58 | 40.5 (12.7) |
Netherlands-population | Unknown | 2,414 | Incalculable | 50 | 42.6 (13.2) |
Netherlands-patient | Members 500 | 337 | 67.4 | 57 | 48.6 (10.6) |
Partners unknown | 115 | Incalculable | |||
Spain-workplace | 1,700 | 999 | 58.8 | 59 | 42.7 (11.9) |
Spain-patient | 300 | 272 | 90.7 | 62 | 41.6 (11.4) |
UK | 720 | 128 | 17.8* | 65 | 48.0 (18.3) |
Non-responder studies | |||||
Germany-nr | 260 | 55 | Unknown | ||
Italy-nr | 202 | 70 | 39.4 | ||
Luxembourg-nr | 357 | 50 | Unknown | ||
Netherlands-nr | 188 | 52 | 38.9 |